6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines
US8288385B2 · kind B2 · utility
7Cited by
1References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 7, 2010 |
| Grant date | Oct 16, 2012 |
| Priority date | — |
| Expiry date | Apr 7, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidine derivatives and their use as P2Y12 receptor antagonists in the treatment and/or prevention of peripheral vascular, of visceral-, hepatic- and renal-vascular, of cardiovascular and of cerebrovascular diseases or conditions associated with platelet aggregation, including thrombosis in humans and other mammals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.